1. American Academy of Pediatrics. Multisystem inflammatory syndrome in children (MIS-C) interim guidance. Retrieved 2 Oct 2020. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/. Accessed 7 Feb 2021.
2. Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol. 2021;73:e13-29.
3. HDVCH guidelines for management of pediatric patient with multisystem inflammatory syndrome. Spectrum health. https://www.spectrumhealth.org/for-health-professionals/clinical-pathways/management-of-multisystem-inflammatory-syndrome-in-children-guideline. Accessed 7 Feb 2021.
4. Simon Junior H, Sakano TMS, Rodrigues RM, Eisencraft AP, Carvalho VEL, Schvartsman C, et al. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician’s point of view. J Pediatr (Rio J). 2021;97:140–59.
5. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–8.